152 related articles for article (PubMed ID: 29503892)
1. A case of recurrent bilateral uveitis independently associated with dabrafenib and pembrolizumab therapy.
Taylor SC; Hrisomalos F; Linette GP; Rao PK
Am J Ophthalmol Case Rep; 2016 Jul; 2():23-25. PubMed ID: 29503892
[TBL] [Abstract][Full Text] [Related]
2. A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
Hanna KS
Pharmacotherapy; 2016 Nov; 36(11):e183-e188. PubMed ID: 27716999
[TBL] [Abstract][Full Text] [Related]
3. Case with metastatic cutaneous malignant melanoma that developed Vogt-Koyanagi-Harada-like uveitis following pembrolizumab treatment.
Enomoto H; Kato K; Sugawara A; Itabashi M; Kondo M
Doc Ophthalmol; 2021 Jun; 142(3):353-360. PubMed ID: 33392895
[TBL] [Abstract][Full Text] [Related]
4. A case of Vogt-Koyanagi-Harada-like uveitis secondary to dabrafenib/trametinib therapy for advanced melanoma.
Brambati M; Giuffrè C; Marchese A; Bandello F; Modorati GM; Miserocchi E
Eur J Ophthalmol; 2022 Jan; 32(1):NP109-NP113. PubMed ID: 32998540
[TBL] [Abstract][Full Text] [Related]
5. Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib.
Draganova D; Kerger J; Caspers L; Willermain F
J Ophthalmic Inflamm Infect; 2015; 5():17. PubMed ID: 26078801
[TBL] [Abstract][Full Text] [Related]
6. Choroidal thickening with serous retinal detachment in BRAF/MEK inhibitor-induced uveitis: A case report.
Kiraly P; Groznik AL; Valentinčič NV; Mekjavić PJ; Urbančič M; Ocvirk J; Mesti T
World J Clin Cases; 2022 Jul; 10(19):6536-6542. PubMed ID: 35979276
[TBL] [Abstract][Full Text] [Related]
7. Vision loss with pembrolizumab treatment: A report of two cases.
Telfah M; Whittaker TJ; C Doolittle G
J Oncol Pharm Pract; 2019 Sep; 25(6):1540-1546. PubMed ID: 30997872
[TBL] [Abstract][Full Text] [Related]
8. A Case of Melanoma-Associated Retinopathy, Uveitis, and Optic Neuritis Associated With Pembrolizumab, Managed With Topical, Intravitreal, and Intravenous Steroids.
Xie K; Kong C; Mehta MC
J Vitreoretin Dis; 2020 Jun; 4(3):220-226. PubMed ID: 37007447
[TBL] [Abstract][Full Text] [Related]
9. Pembrolizumab-related Bilateral Ocular Hypotony, Uveitis, Cataracts, Exudative Retinal, and Choroidal Detachments: An Unusual Success Story.
Golash V; Almeida G
J Immunother; 2020; 43(9):283-285. PubMed ID: 32740318
[TBL] [Abstract][Full Text] [Related]
10. Uveitis and serous retinal detachment secondary to systemic dabrafenib and trametinib.
Rueda-Rueda T; Sánchez-Vicente JL; Moruno-Rodríguez A; Molina-Socola FE; Martínez-Borrego AC; López-Herrero F
Arch Soc Esp Oftalmol (Engl Ed); 2018 Sep; 93(9):458-462. PubMed ID: 29580759
[TBL] [Abstract][Full Text] [Related]
11. A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab.
Abu Samra K; Valdes-Navarro M; Lee S; Swan R; Foster CS; Anesi SD
Eur J Ophthalmol; 2016 Apr; 26(3):e46-8. PubMed ID: 26692064
[TBL] [Abstract][Full Text] [Related]
12. Chronic Unilateral Uveitis with Macular Edema Secondary to Dabrafenib for Pilocytic Astrocytoma.
Chang M; Kuriakose RK; Xu K; Almeida DRP; Chin EK
Case Rep Ophthalmol; 2021; 12(2):574-577. PubMed ID: 34248594
[TBL] [Abstract][Full Text] [Related]
13. Uveitis and Papillitis in the Setting of Dabrafenib and Trametinib Therapy for Metastatic Melanoma: A Case Report.
Lim J; Lomax AJ; McNeil C; Harrisberg B
Ocul Immunol Inflamm; 2018; 26(4):628-631. PubMed ID: 27892777
[TBL] [Abstract][Full Text] [Related]
14. Delayed onset anterior uveitis and macular edema after cessation of pembrolizumab.
Men M; Tsui E
Am J Ophthalmol Case Rep; 2022 Sep; 27():101631. PubMed ID: 35774195
[TBL] [Abstract][Full Text] [Related]
15. Vogt-Kayanagi-Harada-Like Uveitis Induced by Dabrafenib/Trametinib Therapy for Cutaneous Malignant Melanoma.
Kaymak NZ; Kaplan AT
Ophthalmic Surg Lasers Imaging Retina; 2023 Aug; 54(8):477-480. PubMed ID: 37535619
[TBL] [Abstract][Full Text] [Related]
16. Multifocal choroiditis as the first sign of systemic sarcoidosis associated with pembrolizumab.
Lise QK; Audrey AG
Am J Ophthalmol Case Rep; 2017 Apr; 5():92-93. PubMed ID: 29503956
[TBL] [Abstract][Full Text] [Related]
17. A case of panuveitis and retinal vasculitis associated with pembrolizumab therapy for metastatic lung cancer.
Kim KW; Kusuhara S; Tachihara M; Mimura C; Matsumiya W; Nakamura M
Am J Ophthalmol Case Rep; 2021 Jun; 22():101072. PubMed ID: 33796799
[TBL] [Abstract][Full Text] [Related]
18. ACUTE EXUDATIVE PARANEOPLASTIC POLYMORPHOUS VITELLIFORM MACULOPATHY DURING VEMURAFENIB AND PEMBROLIZUMAB TREATMENT FOR METASTATIC MELANOMA.
Sandhu HS; Kolomeyer AM; Lau MK; Shields CL; Schuchter LM; Nichols CW; Aleman TS
Retin Cases Brief Rep; 2019 Spring; 13(2):103-107. PubMed ID: 28614138
[TBL] [Abstract][Full Text] [Related]
19. PEMBROLIZUMAB ADMINISTRATION ASSOCIATED WITH POSTERIOR UVEITIS.
Aaberg MT; Aaberg TM
Retin Cases Brief Rep; 2017 Fall; 11(4):348-351. PubMed ID: 27490976
[TBL] [Abstract][Full Text] [Related]
20. Management of Chronic Hypotony Following Bilateral Uveitis in a Patient Treated with Pembrolizumab for Cutaneous Metastatic Melanoma.
Reid G; Lorigan P; Heimann H; Hovan M
Ocul Immunol Inflamm; 2019; 27(6):1012-1015. PubMed ID: 29672247
[No Abstract] [Full Text] [Related]
[Next] [New Search]
